Goevry World Shopping Magazine

Top Menu

  • DMCA
  • Privacy Policy
  • Contacts
  • UK
  • DE

Main Menu

  • Travel & Lifestyle
  • Fashion
  • Health & Beauty
  • Science & Tech
  • Gift Guides
  • Buying Guides
  • DMCA
  • Privacy Policy
  • Contacts
  • UK
  • DE

logo

Goevry World Shopping Magazine

  • Travel & Lifestyle
    • Goditi la natura, il comfort e l'avventura con hu Village Holidays

      October 26, 2026
      0
    • Encuentra el seguro de viaje adecuado para tu próxima aventura

      October 25, 2026
      0
    • Scopri le avventure sulle isole del Mediterraneo con Ferryhopper

      October 25, 2026
      0
    • Enjoy Great Food and Fun at The Top Hat Restaurant & Bar

      October 25, 2026
      0
    • Discover Tenerife: Your Guide to an Unforgettable Island Getaway

      October 23, 2026
      0
    • Visitas al One World Observatory Group: experiencias inolvidables sobre la ciudad de ...

      October 22, 2026
      0
    • Discover Boston from Above with an Unforgettable View Boston Experience

      October 22, 2026
      0
    • Avanti Travel Insurance: Find the Right Single-Trip Cover for Your Next Holiday

      October 12, 2026
      0
    • Avanti Travel Insurance: Cover Options for Your Next Trip

      October 12, 2026
      0
  • Fashion
    • Descubre las gafas de sol deportivas Eagle Eyes® para rendir al máximo ...

      November 8, 2026
      0
    • Descubre los elegantes bolsos de mujer de Mario Hernández

      November 4, 2026
      0
    • Magliette da uomo ufficiali F**K – Comfort quotidiano e stile moderno

      November 3, 2026
      0
    • Discover Stylish Women's Skirts at The Edit Boutique

      November 2, 2026
      0
    • Celebrate Your Team Pride with Official New York Liberty Merchandise

      October 26, 2026
      0
    • Bolsos unisex de Mario Hernández: el estilo se une a la practicidad ...

      October 10, 2026
      0
    • Camisetas de mujer de Mario Hernández: la comodidad para el día a ...

      October 10, 2026
      0
    • Al diavolo le gonne da acqua: scelte alla moda per l’estate e ...

      October 6, 2026
      0
    • Discover FYTOO’s New Men’s Arrivals – Up to 30% Off

      September 19, 2026
      0
  • Health & Beauty
    • Protect Your Cat’s Health with Petgevity Lifetime Insurance

      November 16, 2026
      0
    • Goditi una doccia rinfrescante con i gel doccia L’Occitane

      November 13, 2026
      0
    • Travel with Confidence: Avanti Pre-Existing Medical Conditions Travel Insurance

      November 4, 2026
      0
    • Hume Body Check: Gewinnen Sie Einblicke in Ihre Gesundheit – mit einem ...

      October 26, 2026
      0
    • Supporting Hope Through the Middle East Emergency Appeal

      October 22, 2026
      0
    • L’Occitane en Provence: Trattamenti nutrienti per la pelle secca

      October 6, 2026
      0
    • Compare Travel Insurance Easily for Every Journey

      September 24, 2026
      0
    • Proteggi la tua salute con le polizze AXA Partners Italia

      September 24, 2026
      0
    • Hume-Gesundheitsempfehlungsprogramm: Teilen Sie Ihre Gesundheitserfahrungen und verdienen Sie Prämien

      September 22, 2026
      0
  • Science & Tech
    • Mejora Buró: Asesoramiento financiero y apoyo para la gestión de la deuda

      October 27, 2026
      0
    • Mejora Buró: Asesoramiento financiero para la mejora de la solvencia crediticia y ...

      October 27, 2026
      0
    • Ricarica dei veicoli elettrici A2A: verso un futuro più sostenibile

      October 23, 2026
      0
    • A2A Illuminazione Pubblica: illuminazione intelligente e sostenibile per le città moderne

      October 23, 2026
      0
    • Teleriscaldamento A2A: energia efficiente per una vita confortevole

      September 29, 2026
      0
    • 3D-Scanner für präzise digitale Erfassung und professionelle Ergebnisse

      September 13, 2026
      0
    • Ratgeber zum Kauf von UV-Druckern: Finden Sie den perfekten Drucker für Ihre ...

      August 8, 2026
      0
    • Entdecken Sie intelligente Software und kreative Ideen für den 3D-Druck mit eufyMake

      August 2, 2026
      0
    • Step Into the World of Secrets, Challenges, and Spy-Inspired Discovery with SPYSCAPE

      July 1, 2026
      0
  • Gift Guides
    • A Social Night Out in London: Monopoly Lifesized Brings Competition to ...

      April 16, 2026
      0
    • Create Lasting Memories with CEWE Photo Book: Your Personalized Keepsake from Boots ...

      May 8, 2025
      0
    • Farrar & Tanner: Luxury and Bespoke Gifts for Every Occasion

      March 25, 2025
      0
    • Tommee Tippee Soothers: The Perfect Blend of Comfort, Style, and Practicality for ...

      March 13, 2025
      0
    • Indulge at the Pinnacle of Private Luxury with Je Joue

      March 8, 2025
      0
    • Get Closer to Your Favorite Stars With Memmo.me’s Exclusive Celebrity Video Messages

      February 25, 2025
      0
    • Waterford Crystal – Mastering the Art of Fine Glassware and Elegant Home ...

      February 15, 2025
      0
    • Discover the World of Exclusive Whiskies with The Scotch Malt Whisky Society

      February 8, 2025
      0
    • Embark on an Exclusive Whisky Journey with The Scotch Malt Whisky Society

      February 8, 2025
      0
  • Buying Guides
    • New York Yankees: Tickets, Games and the Yankee Stadium Experience

      September 29, 2026
      0
    • Elevate Your Game with Premium Golf Balls and Exclusive Deals at Discount ...

      April 17, 2025
      0
    • Aatu’s Premium Dog and Cat Food Delivers High-Quality Nutrition with Natural Ingredients

      April 14, 2025
      0
    • AATU Offers Premium Pet Food Made with Fresh Meat and Natural Ingredients ...

      April 9, 2025
      0
    • Discover the Best Boxsets from Townsendmusic

      February 21, 2025
      0
    • Transform Your Garden into a Bird Haven with These Must-Haves

      January 10, 2025
      0
    • Discovering Unique Whisky Flavours: A Journey of Taste and Tradition

      January 10, 2025
      0
    • Stress-Free Parenting Explore Tommee Tippee’s Range of Baby Care Innovations

      December 26, 2024
      0
    • TOMMEE TIPPEE Innovative Designs for Happy, Healthy Babies and Stress-Free Parents

      December 12, 2024
      0
  • Descubre el ordenador para videojuegos ideal para disfrutar de la mejor experiencia de juego

  • Descubre el bienestar diario con los suplementos en polvo de Aldous

  • Protect Your Cat’s Health with Petgevity Lifetime Insurance

  • Experience the Ultimate Real-Life Monopoly Adventure

  • Entdecken Sie bei 3DPrima UV-Drucklösungen für kreative Projekte

  • Goditi una doccia rinfrescante con i gel doccia L’Occitane

  • Erfrischende Fruchtsäfte und köstliche Getränke für jeden Anlass

  • Descubre las gafas de sol deportivas Eagle Eyes® para rendir al máximo en tu día a día

Science & Tech
Home›Science & Tech›5 Big Questions About New Alzheimer’s Treatments | Chemistry

5 Big Questions About New Alzheimer’s Treatments | Chemistry

By admin1
September 29, 2022
463
0
Share:

[ad_1]

Earlier this week, pharmaceutical companies Biogen and Eisai announced promising results from clinical trials in people with Alzheimer’s disease. A monoclonal antibody treatment called lecanemab reduced cognitive decline in early Alzheimer’s disease patients by 27% compared to a placebo group. A year and a half later. Outside observers say the trial could offer hope to some of the millions of people suffering around the world.

But amidst the excitement, many questions remain, such as why this treatment holds promise when other treatments based on similar strategies have failed. have attempted to target the buildup of amyloid plaques in the brain that are characteristic of Amyloid, clumps of protein that destroy neurons and other cells. The new treatment is apparently the first to do so.

This area is embroiled in controversy. Another Biogen drug, aducanemab, was approved by the Food and Drug Administration (FDA) last year over concerns that the evidence that it relieves patients’ symptoms, despite clearing out amyloid plaques, is not convincing. Other approved Alzheimer’s disease treatments target the presumed root of the disease and only its symptoms. Prior to aducanumab, U.S. authorities hadn’t greenlit an Alzheimer’s drug for nearly 20 years.

chemistry We spoke with Alzheimer’s disease experts about this week’s announcements and the future of lecanemab and the field.

What did clinical trials find?

In a press release, Biogen and Eisai shared the results of a trial involving 1,795 people with early Alzheimer’s disease. Participants were randomized to receive either lecanemab or placebo intravenously every other week for 18 months. The primary test was to compare cognitive decline between the two groups based on the classic dementia scale called the Clinical Dementia Rating-Sum of Boxes (CDR-SB). “I grew up with it and love it,” says Joy Snyder, a neurologist at Washington University in St. Louis, of the assessment tool developed at her institution. She heads the clinical trials arm of the Knights Alzheimer’s Research Center there, and has enrolled nine of her patients in the lecanemab study. One of the benefits of the assessment, Snyder said, is that it includes information from family members about how the patient is living, as well as other measurements.

In this study, people who received lecanemab still had cognitive decline, but progressed 27% slower than those who received placebo. is converted to It’s a slight difference, but I’m hoping for spawning. “This makes us feel a little better. These drugs work,” Snyder says.

Lecanemab had side effects. Most prominent are certain brain abnormalities seen with other anti-amyloid therapies, such as brain swelling and minor hemorrhages. Neuroimaging revealed these concerns in approximately 21% of patients on lecanemab and 9% of his on placebo. These abnormalities are often asymptomatic, but approximately 3% of patients receiving lecanemab did.

Doctors aren’t sure how the gradual slope of cognitive decline will be perceived by patients and their families. You mean?” asks Jonathan Jackson, a cognitive neuroscientist at Massachusetts General Hospital (MGH). “It’s still an open question.” “We’re all feeling cautious and cautious,” says Jackson. “I like to dig into the data before making big conclusions.”

Why did this drug hit its mark when other drugs failed?

No one knows for sure, but there are some theories. One is that lecanemab works a little differently than other anti-amyloid drugs. “When amyloid clumps into these large plaques, some people try to bind or remove it,” Jackson says. Aducanemab primarily binds to amyloid proteins after aggregation. Lecanemab, on the other hand, swoops in earlier and targets ‘protofibrils’, strands that have not yet solidified into plaque. Evidence from many trials and other studies suggests that the earlier in the disease process tracking amyloid plaques is the better. said, “It was always something we had a lot of hopes for.”

Also, the longer trial duration of lecanemab made it easier to detect differences between patients who did not receive experimental treatment and those who did. Assuming Alzheimer’s drugs work, the effect “will be greater the longer the trial goes on,” says Bert de Struper, director of the UK Dementia Research Institute. In fact, Biogen and Eisai noted that lecanemab had no significant effect on his cognition after 12 months, but had a significant effect at 18 months.

The trial only included people with evidence of amyloid in their brains. Mr. De Strooper said.

Is a diverse study population important?

One of the notable features of the lecanemab trial was that approximately 25% of the participants were black or Hispanic. “We like to think that people have equal access to our science, but that’s often not the case,” said Jason Karlawish, co-director of the Penn Memory Center at the University of Pennsylvania.

Additionally, these populations are at higher risk of Alzheimer’s disease than non-Hispanic whites, and researchers don’t fully understand why. “We want a drug that works for everyone,” says Snyder.

For Jackson, who studies the impact of diversity and inclusion in human subjects research and directs the Center for Community Access, Recruitment and Engagement Studies at MGH and Harvard Medical School, the new trial population represents an opportunity to study this disparity. provide. One theory is that black and Hispanic people may be at higher risk of dementia because they have higher rates of diabetes and cardiovascular disease, which can affect the brain, he explains. Examining how well lecanemab (“an anti-amyloid therapy that truly focuses on the pure symptoms of Alzheimer’s disease”) worked in black and Hispanic participants will provide biological insight into their disease. “We believe this will be the first opportunity to have sufficient data on ethnic and racial minorities in Alzheimer’s trials,” says Jackson.

What impact will Alzheimer’s have on the field?

Lecanemab is “not a cure, it’s not going to make people better,” warns Snyder. (Nevertheless, scientists warn that they would feel more comfortable if companies released more complete trial data, especially after their experience with aducanumab.)

Other anti-amyloid antibodies are in trials, and De Strooper said he would like to see the development of small-molecule drugs that can be swallowed instead of injected. But Jackson hopes that “a new treatment coming out in three or four years has the potential to achieve that goal by far.” Better performance could come from researchers learning how to build better and safer anti-amyloid therapies and determining who is best suited to receive them, he said. increase.

That said, “I don’t think we can just focus on amyloid just yet,” Snyder says. Future anti-amyloid treatments may or may not be better than this. “This drug may work as well as we can,” she says. This is especially true for those who already have symptoms. “We don’t treat cancer with her one drug, we drink cocktails,” she says. Physicians need a similarly diverse toolkit for Alzheimer’s disease, where inflammation and other factors are also important contributors.

What questions do you have?

many! First, researchers would like to see more data from the lecanemab trial, which is expected to be released in late November. Given that, there is a lot of interest and anxiety about how the deployment of lecanemab will proceed in the real world. I suspect that people who take it may have a higher risk of brain hemorrhage from lecanemab.

Karlawish wants more information about how patients are doing in the long term. At this point, assuming the company’s announcements are consistent with their trial data, the treatment appears to be “worth taking,” or at least worth considering for those for whom it was designed. However, “the big question in clinical practice is how well a drug works and how long it should last.” Karlawish is looking at registries that track people undergoing treatment to help guide doctors and families facing difficult choices. I think I want to do. “We don’t have enough workforce to deploy this drug and similar drugs to clinical practice,” he says.

Lecanemab is now being tested in people with evidence of amyloid—And it is often a familial or genetic risk factor, but without symptoms. The compelling question is whether treatment can stem dementia: De Strooper says he should show subtle signs of the disease at least 10 years before obvious symptoms appear. Preventing their deterioration is another frontier.

[ad_2]

Source link

Tagsbestblackclassiccommunitydrinkfamilyfocusfoodhopejoylovenewpeopleschoolshowtheukworkworldyou
Previous Article

Press Releases | Press | Chair’s Newsroom ...

Next Article

A Decade of Daily Press: Community, Clothing, ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0

Related articles More from author

  • Travel & Lifestyle

    The Future of College Education in America and Around the World, with Darryl J. Pines

    September 5, 2022
    By admin1
  • All

    Free ICT skills workshop for female entrepreneurs

    September 20, 2022
    By admin1
  • Fashion

    Iconic fashion alcoves updated with old-world charm – WWD

    September 18, 2022
    By admin1
  • Health & Beauty

    Doctor Tip: The Weight of Evidence Supports Avoiding Oils for Optimal Health

    September 15, 2022
    By admin1
  • Travel & Lifestyle

    AnyVan: Your One-Stop Solution for All Moving Needs

    December 27, 2023
    By admin1
  • All

    Radiance empowering young people in the right direction through proper digital marketing knowledge

    August 29, 2022
    By admin1

You may interested

  • Science & Tech

    ‘The Sound of Molecules’ mixes science and music in WonderLab’s show

  • Science & Tech

    When should you use your TV over the monitor?

  • Science & Tech

    Mask duty covers some and relax in others. Science shows the effectiveness of masks.

Search

Categories

  • All (1,243)
  • Animal Food (23)
  • Books & Novels (24)
  • Buying Guides (21)
  • Buying Guides (32)
  • Donation and Services (7)
  • Export Test (21)
  • Fashion (1,776)
  • Fashis (1)
  • Fitness & Health (21)
  • Food & Drinks (28)
  • Gift Guides (23)
  • Gift Guides (52)
  • Health & Beauty (1,634)
  • Health & Beauty (22)
  • Home&Living (242)
  • Marketing & Safety Solutions (5)
  • Mobility & Lifestyle (9)
  • Movies (3)
  • Non classifié(e) (2)
  • Nutritional Innovation (4)
  • Photo Gifts (1)
  • Price Comparison (1)
  • Science & Tech (1,353)
  • Science & Tech (1)
  • Sports (39)
  • Technology (201)
  • Travel & Lifestyle (1,786)
  • Travel & Lifestyle (17)
logo

Goevry is not just another run-of-the-mill magazine; it's a transformative journey that transcends the boundaries of traditional fashion publications. Our team of passionate experts, seasoned fashionistas, and visionary writers collaborate to curate a diverse range of thought-provoking features that delve into the very essence of style, culture, and identity.

  • Recent

  • Popular

  • Descubre el ordenador para videojuegos ideal para disfrutar de la mejor experiencia de juego

    By techsmillion
    November 17, 2026
  • Descubre el bienestar diario con los suplementos en polvo de Aldous

    By techsmillion
    November 16, 2026
  • A Homecoming Story, An Original Documentary Featuring Giannis Antetokounmpo

    By admin1
    January 17, 2024
  • Discover the Heart of New York from Its Highest Point at One World Observatory

    By admin1
    May 4, 2025

Follow us

  • DMCA
  • Privacy Policy
  • About Us
  • Contacts
©2024 Copyright Goevry | All Rights Reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy